198 related articles for article (PubMed ID: 26631239)
1. Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases.
Barbier CE; Garske-Román U; Sandström M; Nyman R; Granberg D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1425-31. PubMed ID: 26631239
[TBL] [Abstract][Full Text] [Related]
2. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.
King J; Quinn R; Glenn DM; Janssen J; Tong D; Liaw W; Morris DL
Cancer; 2008 Sep; 113(5):921-9. PubMed ID: 18618495
[TBL] [Abstract][Full Text] [Related]
3. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
[TBL] [Abstract][Full Text] [Related]
4. Radioembolization with
Braat AJAT; Ahmadzadehfar H; Kappadath SC; Stothers CL; Frilling A; Deroose CM; Flamen P; Brown DB; Sze DY; Mahvash A; Lam MGEH
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):246-253. PubMed ID: 31646375
[TBL] [Abstract][Full Text] [Related]
5. Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.
Peker A; Çiçek O; Soydal Ç; Küçük NÖ; Bilgiç S
Diagn Interv Radiol; 2015; 21(1):54-9. PubMed ID: 25430526
[TBL] [Abstract][Full Text] [Related]
6. 90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.
Ezziddin S; Meyer C; Kahancova S; Haslerud T; Willinek W; Wilhelm K; Biersack HJ; Ahmadzadehfar H
J Nucl Med; 2012 Nov; 53(11):1663-9. PubMed ID: 22988059
[TBL] [Abstract][Full Text] [Related]
7. Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study.
Kalinowski M; Dressler M; König A; El-Sheik M; Rinke A; Höffken H; Gress TM; Arnold R; Klose KJ; Wagner HJ
Digestion; 2009; 79(3):137-42. PubMed ID: 19307736
[TBL] [Abstract][Full Text] [Related]
8. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.
Kucuk ON; Soydal C; Lacin S; Ozkan E; Bilgic S
World J Surg Oncol; 2011 Aug; 9():86. PubMed ID: 21819613
[TBL] [Abstract][Full Text] [Related]
9. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: initial experience at a single center.
Arslan N; Emi M; Alagöz E; Ustünsöz B; Oysul K; Arpaci F; Uğurel S; Beyzadeoğlu M; Ozgüven MA
Vojnosanit Pregl; 2011 Apr; 68(4):341-8. PubMed ID: 21627019
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor.
Maccauro M; Follacchio GA; Spreafico C; Coppa J; Seregni E
Clin Nucl Med; 2019 Apr; 44(4):e286-e288. PubMed ID: 30789395
[TBL] [Abstract][Full Text] [Related]
11. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; Philips R; Thillainayagam A; Bansi D; Rubello D; Limongelli P; Woo K; Habib NA
Eur J Surg Oncol; 2007 Jun; 33(5):597-602. PubMed ID: 17433608
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
Omed A; Lawrance JA; Murphy G; Laasch HU; Wilson G; Illidge T; Tipping J; Zivanovic M; Jeans S
Clin Radiol; 2010 Sep; 65(9):720-8. PubMed ID: 20696299
[TBL] [Abstract][Full Text] [Related]
13. Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease.
Turkmen C; Ucar A; Poyanli A; Vatankulu B; Ozkan G; Basaran M; Serin K; Sanli Y; Adalet I
Cancer Biother Radiopharm; 2013 Sep; 28(7):534-40. PubMed ID: 23647219
[TBL] [Abstract][Full Text] [Related]
14. Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.
McStay MK; Maudgil D; Williams M; Tibballs JM; Watkinson AF; Caplin ME; Buscombe JR
Radiology; 2005 Nov; 237(2):718-26. PubMed ID: 16192318
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT.
Kucuk ON; Soydal C; Araz M; Bilgic S; Ibis E
Clin Nucl Med; 2013 Jul; 38(7):e283-9. PubMed ID: 23531737
[TBL] [Abstract][Full Text] [Related]
16. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
[TBL] [Abstract][Full Text] [Related]
17. Safety of repeated radioembolizations in patients with advanced primary and secondary liver tumors and progressive disease after first selective internal radiotherapy.
Zarva A; Mohnike K; Damm R; Ruf J; Seidensticker R; Ulrich G; Seidensticker M; Pech M; Ricke J; Amthauer H
J Nucl Med; 2014 Mar; 55(3):360-6. PubMed ID: 24516256
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.
Gibbs P; Do C; Lipton L; Cade DN; Tapner MJ; Price D; Bower GD; Dowling R; Lichtenstein M; van Hazel GA
BMC Cancer; 2015 Oct; 15():802. PubMed ID: 26503593
[TBL] [Abstract][Full Text] [Related]
19. Radioembolization with
Braat AJAT; Kappadath SC; Ahmadzadehfar H; Stothers CL; Frilling A; Deroose CM; Flamen P; Brown DB; Sze DY; Mahvash A; Lam MGEH
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):413-425. PubMed ID: 30603975
[TBL] [Abstract][Full Text] [Related]
20. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
Stubbs RS; O'Brien I; Correia MM
ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]